Frontier Sciences Llc | |
1607 Capitol Ave Ste 422 Cheyenne WY 82001-4525 | |
(303) 309-2769 | |
Not Available |
Full Name | Frontier Sciences Llc |
---|---|
Speciality | Clinic/center - Primary Care |
Location | 1607 Capitol Ave Ste 422, Cheyenne, Wyoming |
Authorized Official Name and Position | Muhammad Hasan (MANAGING OFFICER) |
Authorized Official Contact | 3033092769 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Frontier Sciences Llc 1607 Capitol Ave Ste 422 Cheyenne WY 82001-4525 Ph: (303) 309-2769 | Frontier Sciences Llc 1607 Capitol Ave Ste 422 Cheyenne WY 82001-4525 Ph: (303) 309-2769 |
NPI Number | 1538942362 |
---|---|
Provider Enumeration Date | 08/15/2023 |
Last Update Date | 08/15/2023 |
Identifier | Type | State | Issuer |
---|---|---|---|
1538942362 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Primary |
News Archive
Pluristem Therapeutics Inc. today announced that it will present at the New England-Israel Life Sciences Summit at the Brandeis International Business School in Waltham, Mass. Zami Aberman, chairman and CEO of Pluristem will present an update on the company and an overview of its technology at 9:40 EDT, Oct 27, 2009.
HAIR loss is one of the most distressing side-effects of cancer treatment and can even deter some patients from undergoing life-saving chemotherapy. But researchers at the University of Huddersfield are establishing the scientific basis for a rapidly-advancing scalp cooling technology that can ensure hair retention in a vast number of cases.
DURECT Corporation today announced that it has initiated a multi-dose Phase 1 clinical trial of an oral formulation of DUR-928, the lead molecule in DURECT's Epigenomic Regulator Program.
Once-daily treatment of patients with chronic obstructive pulmonary disease (COPD) with an inhaler combining fluticasone furoate (FF), umeclidinium (UMEC) and vilanterol (VI) reduced all-cause mortality by 42 percent, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
New stem cell lines developed from the skin of adults living with bipolar disorder are providing researchers at the University of Michigan Health System an unprecedented opportunity to delve into the genetic and biological underpinnings of the devastating mood disorder.
› Verified 9 days ago
Healthreach Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2030 Bluegrass Cir, Cheyenne, WY 82009 Phone: 307-635-3500 Fax: 307-635-2199 | |
University Of Wyoming Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 820 E 17th St, Cheyenne, WY 82001 Phone: 307-777-7911 Fax: 307-777-7911 | |
North Cheyenne Family Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6015 Sycamore Rd, 1st Floor, Cheyenne, WY 82009 Phone: 307-514-1300 | |
Crossroads Healthcare Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 Central Ave, Ste 100, Cheyenne, WY 82007 Phone: 307-632-8064 Fax: 307-632-6131 | |
Clinical Decision Medical Services, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1807 Capitol Ave, Suite 201, Cheyenne, WY 82001 Phone: 307-286-1833 | |
Physician Management Services Of Wyoming, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1331 Prairie Ave Ste 2, Cheyenne, WY 82009 Phone: 888-829-8550 | |
Pauljordanwashburnmd, Llc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5720 Osage Ave, 3-301, Cheyenne, WY 82009 Phone: 970-518-9394 |